Biosensor Platform
By combining multi-GHz BAW detection arrays with microfluidics and electronics, this rapid diagnostic platform is designed to deliver centralized lab results at the point of care, breaking the technological barrier limiting the ubiquitous deployment of liquid-based biosensors across all markets.
Device Type
POC Immunodiagnostic Platform
Application Area
Immunology, Molecular (in R&D)
Client
Qorvo® Biotechnologies, LLC
Role of BIT
Product Development, Manufacturing, After-Sales Services
History
Not on the market yet; non-human commercial customer launch targeted Q1 2020
Qorvo Biotechnologies, LLC is a wholly owned subsidiary of Qorvo, Inc. that is developing a point-of-care (POC) diagnostics system based on a sensor application of Qorvo’s Bulk Acoustic Wave (BAW) filter technology.
By combining multi-GHz BAW detection arrays with microfluidics and electronics, this rapid diagnostic platform is designed to deliver centralized lab results at the point of care, breaking the technological barrier limiting the ubiquitous deployment of liquid-based biosensors across all markets.
| Test Type | Bulk Acoustic Wave (BAW) Enzyme Immunoassay |
| Sample Types | Whole Blood, Serum, Plasma, Saliva, Urine, Stool |
| Sample Volume | 100 µl |
| Assay Applications | Cardiac, Infectious Disease, Hormone as examples. Fundamentally any Immunoassay where known binding occurs. |
| Throughput | Singleplex: 4 – 6 Tests/ h Multiplex (Gen 1: 8 – 12 Tests/ h; Gen 2: up to 60 Tests/ h) |
| Walk Away Time | <10 – 15 min |
| Time to First Result | <10 – 15 min |
| Analysis Type | Sequential |
| Sample Loading Capabilities | Manual Pipette Dispensing |
| Input & Output | Multiple USB ports Optional barcode scanner Optional printer WiFi, ethernet, optional cellular |
| Interface | Capacitive Touch Display |
| Dimensions | 21.6 cm x 24.9 cm x 15 cm (H x W x D) |
| Weight | 3 kg |
| Power | AC 100- 240V 50/60 Hz <12W (7h battery life) |
